FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

320711006: Clemastine+phenylpropanolamine 0.5/25mg tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    463416017 Clemastine+phenylpropanolamine 0.5/25mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1189129015 Clemastine+phenylpropanolamine 0.5/25mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Clemastine+phenylpropanolamine 0.5/25mg tablet Is a Product containing clemastine and phenylpropanolamine (medicinal product) false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethanolamine false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clemastine (substance) false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylpropanolamine (substance) false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cardiovascular agent (substance) false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet Is a Clemastine- and phenylpropanolamine-containing product in oral dose form false Inferred relationship Some
    Clemastine+phenylpropanolamine 0.5/25mg tablet Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start